Main Outcome Measure: Cardiac death or nonfatal myocardial infarction (MI).
主要终点事件：心血管死亡或非致死性心肌梗塞。
The primary end point was the rate of death, nonfatal myocardial infarction, and repeat revascularization at 1 year.
主要终点为术后1年的死亡、非致死性心肌梗死和再次再血管化。
The secondary outcome measure was a composite of death from cardiovascular causes and nonfatal myocardial infarction.
次级预后终点为综合心脏血管原因的死亡、与非致命性心肌梗塞。
A limitation of the study was that the trial lacked statistical power for the composite outcome of risk for death from cardiovascular causes or nonfatal myocardial infarction.
这项研究的一个限制是缺乏心脏血管原因死亡或是非致命性心肌梗塞综合预后的统计力量。
Main outcome Measures Adverse cardiovascular outcomes, including the primary outcomes which was the first occurrence of all-cause death, nonfatal myocardial infarction, or nonfatal stroke.
主要终点比较心血管不良事件，这些事件包括病人死亡的首要原因、非致死的心肌梗死、非致死的脑卒中。
Over an average of 8.2 years of follow-up, 554 participants experienced fatal and nonfatal cardiovascular events, including myocardial infarction, stroke, coronary artery disease, and heart failure.
平均随访8.2年，共有554名参与者出现致死性和非致死性心血管事件，包括心肌梗死、卒中、冠心病和心力衰竭。
Over an average of 8.2 years of follow-up, 554 participants experienced fatal and nonfatal cardiovascular events, including myocardial infarction, stroke, coronary artery disease, and heart failure.
平均随访8.2年，共有554名参与者出现致死性和非致死性心血管事件，包括心肌梗死、卒中、冠心病和心力衰竭。
应用推荐